HIV therapeutics: confronting adherence
- PMID: 9356962
- DOI: 10.1016/s1055-3290(97)80008-8
HIV therapeutics: confronting adherence
Similar articles
-
Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.Nurse Pract. 1998 Feb;23(2):102-4, 106. Nurse Pract. 1998. PMID: 9513221 No abstract available.
-
[Synthetic HIV proteinase inhibitors and new prospects for drug therapy of HIV infections and AIDS].Vopr Virusol. 1997 Nov-Dec;42(6):284-6. Vopr Virusol. 1997. PMID: 9499245 Russian. No abstract available.
-
[Possible cardiovascular complications. What leads to "switching"].MMW Fortschr Med. 2002 Apr 9;144 Suppl 1:82. MMW Fortschr Med. 2002. PMID: 12043091 German. No abstract available.
-
Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention.Health Psychol. 1998 Jul;17(4):310-9. doi: 10.1037//0278-6133.17.4.310. Health Psychol. 1998. PMID: 9697940 Review.
-
Current clinical treatments of AIDS.Adv Pharmacol. 2008;56:27-73. doi: 10.1016/S1054-3589(07)56002-3. Adv Pharmacol. 2008. PMID: 18086408 Review. No abstract available.
Cited by
-
Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques.PLoS One. 2018 May 25;13(5):e0197906. doi: 10.1371/journal.pone.0197906. eCollection 2018. PLoS One. 2018. PMID: 29799875 Free PMC article.
-
A proposal for quality standards for measuring medication adherence in research.AIDS Behav. 2013 Jan;17(1):284-97. doi: 10.1007/s10461-012-0172-7. AIDS Behav. 2013. PMID: 22407465 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical